110 related articles for article (PubMed ID: 19936977)
1. GSK3B and schizophrenia: a case not closed.
Sand PG; Domani M; Smesny S
Psychopharmacology (Berl); 2010 Feb; 208(2):333-4; author reply 335-6. PubMed ID: 19936977
[No Abstract] [Full Text] [Related]
2. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.
Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; Wong AH; Kennedy JL
Psychopharmacology (Berl); 2008 Oct; 200(2):177-86. PubMed ID: 18500637
[TBL] [Abstract][Full Text] [Related]
3. [Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders].
Ivanova SA; Losenkov IS; Bokhan NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(6):93-100. PubMed ID: 25075421
[TBL] [Abstract][Full Text] [Related]
4. No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.
Ikeda M; Iwata N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Ozaki N
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):90-2. PubMed ID: 15719395
[TBL] [Abstract][Full Text] [Related]
5. The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.
Chen J; Wang M; Waheed Khan RA; He K; Wang Q; Li Z; Shen J; Song Z; Li W; Wen Z; Jiang Y; Xu Y; Shi Y; Ji W
J Affect Disord; 2015 Oct; 185():149-55. PubMed ID: 26186530
[TBL] [Abstract][Full Text] [Related]
6. No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine.
Tsai SJ; Hong CJ; Yu YW; Lin CH; Liu LL
Schizophr Res; 2003 Dec; 65(1):27-32. PubMed ID: 14623371
[TBL] [Abstract][Full Text] [Related]
7. GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
Tang H; Shen N; Jin H; Liu D; Miao X; Zhu LQ
Mol Neurobiol; 2013 Dec; 48(3):404-11. PubMed ID: 23440732
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
Masellis M; Basile VS; Ozdemir V; Meltzer HY; Macciardi FM; Kennedy JL
Biol Psychiatry; 2000 Feb; 47(3):252-66. PubMed ID: 10682223
[TBL] [Abstract][Full Text] [Related]
9. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
Benedetti F; Poletti S; Radaelli D; Bernasconi A; Cavallaro R; Falini A; Lorenzi C; Pirovano A; Dallaspezia S; Locatelli C; Scotti G; Smeraldi E
Genes Brain Behav; 2010 Jun; 9(4):365-71. PubMed ID: 20113358
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects.
Kohn Y; Ebstein RP; Heresco-Levy U; Shapira B; Nemanov L; Gritsenko I; Avnon M; Lerer B
Eur Neuropsychopharmacol; 1997 Feb; 7(1):39-43. PubMed ID: 9088883
[TBL] [Abstract][Full Text] [Related]
11. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients.
Hong CJ; Yu YW; Lin CH; Tsai SJ
Neurosci Lett; 2003 Oct; 349(3):206-8. PubMed ID: 12951204
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of polymorphism in the promoter region of the alpha2a-adrenoceptor gene with schizophrenia and clozapine response.
Tsai SJ; Wang YC; Yu Younger WY; Lin CH; Yang KH; Hong CJ
Schizophr Res; 2001 Apr; 49(1-2):53-8. PubMed ID: 11343863
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
de Matos LP; Santana CV; Souza RP
Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
[TBL] [Abstract][Full Text] [Related]
14. An association study of the neurotensin receptor gene with schizophrenia and clozapine response.
Huezo-Diaz P; Arranz MJ; Munro J; Osborne S; Makoff A; Kerwin RW; Austin J; O'Donovan M
Schizophr Res; 2004 Feb; 66(2-3):193-5. PubMed ID: 15061255
[No Abstract] [Full Text] [Related]
15. [The relationship between glycogen synthase kinase-3 beta (GSK3B) -50T/C -1727A/T polymorphisms and alcoholism].
Yoshihara E; Aoki J; Kurihara K; Numajiri M; Iwahashi K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2011 Dec; 46(6):570-5. PubMed ID: 22413565
[TBL] [Abstract][Full Text] [Related]
16. Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia.
Ferrari M; Bolla E; Bortolaso P; Callegari C; Poloni N; Lecchini S; Vender S; Marino F; Cosentino M
Psychiatry Res; 2012 Dec; 200(2-3):1014-7. PubMed ID: 22901441
[TBL] [Abstract][Full Text] [Related]
17. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
Zhao Z; Ksiezak-Reding H; Riggio S; Haroutunian V; Pasinetti GM
Schizophr Res; 2006 May; 84(1):1-14. PubMed ID: 16581231
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK
Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.
Ronai Z; Kovacs-Nagy R; Szantai E; Elek Z; Sasvari-Szekely M; Faludi G; Benkovits J; Rethelyi JM; Szekely A
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):217-22. PubMed ID: 24677591
[TBL] [Abstract][Full Text] [Related]
20. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.
Freyberg Z; Ferrando SJ; Javitch JA
Am J Psychiatry; 2010 Apr; 167(4):388-96. PubMed ID: 19917593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
